Clinical Trial Update: Exenatide For Reducing the Reinforcing Effects of Cocaine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating exenatide for reducing reinforcing effects in Cocaine Use Disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Christopher D. Verrico | Conditions: Cocaine Use Disorder | Phase 1 | Status: WITHDRAWN